71.66
price up icon1.24%   0.88
 
loading
전일 마감가:
$70.78
열려 있는:
$70.85
하루 거래량:
2.86M
Relative Volume:
0.71
시가총액:
$28.72B
수익:
$4.03B
순이익/손실:
$576.20M
주가수익비율:
50.11
EPS:
1.43
순현금흐름:
$630.70M
1주 성능:
+4.51%
1개월 성능:
-2.57%
6개월 성능:
-2.42%
1년 성능:
-48.08%
1일 변동 폭
Value
$70.36
$72.28
1주일 범위
Value
$65.11
$72.28
52주 변동 폭
Value
$57.52
$138.81

덱스컴 Stock (DXCM) Company Profile

Name
명칭
Dexcom Inc
Name
전화
(858) 200-0200
Name
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
직원
9,600
Name
트위터
@dexcom
Name
다음 수익 날짜
2024-10-24
Name
최신 SEC 제출 서류
Name
DXCM's Discussions on Twitter

DXCM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
DXCM
Dexcom Inc
71.66 28.72B 4.03B 576.20M 630.70M 1.43
Medical Devices icon
ABT
Abbott Laboratories
128.85 225.27B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
101.90 138.41B 17.55B 2.03B 2.37B 1.37
Medical Devices icon
SYK
Stryker Corp
365.06 129.62B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
84.16 107.92B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
76.04 40.53B 5.54B 4.18B 259.90M 7.00

덱스컴 Stock (DXCM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-10 개시 Mizuho Outperform
2025-02-03 업그레이드 Redburn Atlantic Neutral → Buy
2025-01-16 업그레이드 Robert W. Baird Neutral → Outperform
2024-07-26 다운그레이드 JP Morgan Overweight → Neutral
2024-07-26 다운그레이드 Robert W. Baird Outperform → Neutral
2024-05-30 개시 Redburn Atlantic Neutral
2024-03-12 개시 RBC Capital Mkts Outperform
2023-05-30 재개 Morgan Stanley Equal-Weight
2023-04-17 업그레이드 Raymond James Outperform → Strong Buy
2023-03-29 개시 UBS Buy
2023-01-26 개시 Wolfe Research Outperform
2022-10-18 개시 Barclays Equal Weight
2022-10-12 개시 Jefferies Buy
2022-07-15 개시 Bernstein Outperform
2022-03-02 재개 BofA Securities Buy
2022-02-03 업그레이드 BTIG Research Neutral → Buy
2022-01-19 업그레이드 Wells Fargo Equal Weight → Overweight
2022-01-07 업그레이드 Guggenheim Neutral → Buy
2021-10-18 다운그레이드 Guggenheim Buy → Neutral
2021-07-21 재개 Cowen Outperform
2021-05-28 업그레이드 Wells Fargo Underweight → Equal Weight
2021-05-25 개시 Barclays Overweight
2021-04-15 개시 Atlantic Equities Overweight
2021-01-06 업그레이드 UBS Neutral → Buy
2020-10-02 다운그레이드 Wells Fargo Equal Weight → Underweight
2020-05-27 재확인 Piper Sandler Overweight
2020-05-14 개시 Wells Fargo Equal Weight
2020-03-05 개시 Citigroup Buy
2019-11-07 재확인 Canaccord Genuity Buy
2019-11-07 업그레이드 Guggenheim Neutral → Buy
2019-10-23 개시 Stifel Buy
2018-11-28 개시 UBS Neutral
2018-10-19 업그레이드 Goldman Sell → Neutral
2018-09-12 업그레이드 Northland Capital Under Perform → Market Perform
2018-08-02 재확인 Canaccord Genuity Buy
2018-07-02 업그레이드 Raymond James Mkt Perform → Outperform
2018-06-08 업그레이드 JP Morgan Neutral → Overweight
2018-05-11 개시 BofA/Merrill Buy
2018-05-03 재확인 Canaccord Genuity Buy
2018-04-04 개시 Goldman Sell
2018-04-04 개시 Guggenheim Neutral
2018-03-23 업그레이드 Robert W. Baird Neutral → Outperform
2018-01-04 다운그레이드 Northland Capital Market Perform → Under Perform
2017-09-28 재확인 Wedbush Outperform
모두보기

덱스컴 주식(DXCM)의 최신 뉴스

pulisher
02:08 AM

Press Release Distribution & PR Platform - ACCESS Newswire

02:08 AM
pulisher
Apr 24, 2025

DexCom Inc (DXCM) Stock Price Up 5.21% on Apr 24 - GuruFocus

Apr 24, 2025
pulisher
Apr 23, 2025

Kuehn Law Encourages Investors of DexCom, Inc. to Contact Law Firm - The Malaysian Reserve

Apr 23, 2025
pulisher
Apr 22, 2025

Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders - GlobeNewswire

Apr 22, 2025
pulisher
Apr 22, 2025

FDA Approves Dexcom G5® Mobile Continuous Glucose Monitoring System - ADVFN

Apr 22, 2025
pulisher
Apr 22, 2025

Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U - Business Wire

Apr 22, 2025
pulisher
Apr 22, 2025

Stocks Update From Health Care Sector -- DexCom, Alkermes, BioCryst Pharmaceuticals, Anacor Pharmaceuticals and Endologix - ADVFN

Apr 22, 2025
pulisher
Apr 21, 2025

DXCMDexCom Reports Second Quarter 2018 Financial Results - ADVFN

Apr 21, 2025
pulisher
Apr 20, 2025

Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB - ADVFN

Apr 20, 2025
pulisher
Apr 18, 2025

DexCom, Inc. (NASDAQ:DXCM) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - TradingView

Apr 17, 2025
pulisher
Apr 17, 2025

Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap - Investegate

Apr 17, 2025
pulisher
Apr 16, 2025

DexCom Execs Sued For Allegedly Misleading Growth Claims - Law360

Apr 16, 2025
pulisher
Apr 16, 2025

DexCom (NasdaqGS:DXCM) Gains FDA Clearance For Dexcom G7 System - Yahoo Finance

Apr 16, 2025
pulisher
Apr 16, 2025

Alert on DexCom from law firm's press release withdrawn - marketscreener.com

Apr 16, 2025
pulisher
Apr 15, 2025

RBC Cuts Price Target on DexCom to $100 From $115, Keeps Outperform Rating - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

BTIG Adjusts DexCom (DXCM) Price Target Ahead of MedTech Q1 Resu - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Clears Dexcom G7 15 Day for Continuous Glucose Monitoring - Clinical Advisor

Apr 15, 2025
pulisher
Apr 14, 2025

BTIG Adjusts DexCom (DXCM) Price Target Ahead of MedTech Q1 Results | DXCM Stock News - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance - MSN

Apr 14, 2025
pulisher
Apr 11, 2025

FDA clears Dexcom G7 15 Day - BioWorld MedTech

Apr 11, 2025
pulisher
Apr 11, 2025

What to Expect From DexCom's Next Quarterly Earnings Report - Nasdaq

Apr 11, 2025
pulisher
Apr 11, 2025

What Does the Market Think About DexCom? - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

DexCom signals 14% revenue growth target for 2025 with new product launches and expanded coverage - MSN

Apr 11, 2025
pulisher
Apr 11, 2025

What To Expect From DexCom's Next Quarterly Earnings Report - Barchart.com

Apr 11, 2025
pulisher
Apr 11, 2025

DexCom (DXCM) Faces Market Challenges Amid Strategic Changes - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

DexCom (DXCM) Anticipates Growth Driven by Strategic Initiatives - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

DexCom (DXCM) Gains on FDA Approval for G7 15 Day Monitoring Sys - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

FDA clears Dexcom G7 15-Day continuous glucose monitor - TechTarget

Apr 11, 2025
pulisher
Apr 10, 2025

Mizuho Initiates Coverage of DexCom (XTRA:DC4) with Outperform Recommendation - Nasdaq

Apr 10, 2025
pulisher
Apr 10, 2025

Dexcom G7 15 Day CGM system cleared by FDA for adults - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Dexcom G7 15 Day CGM System Cleared by FDA - Patient Care Online

Apr 10, 2025
pulisher
Apr 10, 2025

DexCom (DXCM) Faces Investor Backlash After Disappointing Earnings ReportHagens Berman - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

Dexcom nets FDA clearance for 15-day CGM - MedTech Dive

Apr 10, 2025
pulisher
Apr 10, 2025

Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With DexcomPanhandle - Panhandle - News Channel

Apr 10, 2025
pulisher
Apr 10, 2025

FDA Approves New DexCom Diabetes Device - Yahoo Finance

Apr 10, 2025
pulisher
Apr 10, 2025

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch - Benzinga

Apr 10, 2025

덱스컴 (DXCM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$68.42
price up icon 2.00%
medical_devices PHG
$25.03
price up icon 1.25%
medical_devices STE
$225.00
price down icon 0.60%
medical_devices ZBH
$101.51
price up icon 0.01%
medical_devices EW
$76.04
price up icon 1.21%
자본화:     |  볼륨(24시간):